Publication | Closed Access
(−)-Epigallocatechin- 3 -gallate is a new inhibitor of hepatitis C virus entry
276
Citations
31
References
2011
Year
EGCG is a new, interesting anti-HCV molecule that could be used in combination with other direct-acting antivirals. Furthermore, it is a novel tool to further dissect the mechanisms of HCV entry into the hepatocyte.
| Year | Citations | |
|---|---|---|
Page 1
Page 1